Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

Microbot Medical Inc. (NASDAQ:MBOT) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.99 and traded as high as $1.03. Microbot Medical shares last traded at $1.01, with a volume of 189,160 shares traded.

Microbot Medical Price Performance

The firm has a market cap of $15.60 million, a PE ratio of -1.10 and a beta of 1.64. The company’s 50 day moving average price is $0.94 and its 200 day moving average price is $0.99.

Microbot Medical (NASDAQ:MBOT) last posted its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). Sell-side analysts expect that Microbot Medical Inc. will post -0.66 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Microbot Medical

An institutional investor recently bought a new position in Microbot Medical stock. Thoroughbred Financial Services LLC acquired a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned approximately 0.33% of Microbot Medical as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 16.30% of the company’s stock.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.